Analysts have been eager to weigh in on the Healthcare sector with new ratings on SOPHiA GENETICS (SOPH – Research Report), Calliditas Therapeutics (CALT – Research Report) and Ascend Wellness Holdings LLC (AAWH – Research Report).
Ascend Wellness Holdings LLC (AAWH)
Needham analyst Matt McGinley maintained a Hold rating on Ascend Wellness Holdings LLC today. The company’s shares closed last Tuesday at $1.00.
According to TipRanks.com, McGinley is ranked #5215 out of 8601 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Ascend Wellness Holdings LLC with a $3.85 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on SOPH:
- SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2023
- SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2023 on November 7, 2023
- Sophia Genetics announces collaboration with MSK Cancer Center and AstraZeneca
- Sophia Genetics management to meet virtually with BTIG
- Laboratorio Curie expands relationship with SOPHiA GENETICS
